Beranda › Diabetes Tipe 2 › Idaho › Idaho Falls
Uji klinis Diabetes Tipe 2 di Idaho Falls, ID
5 studi untuk Diabetes Tipe 2 mencari peserta di lokasi sekitar Idaho Falls (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Menerima pesertaFase 3
- Rocky Mountain Clinical Research - Idaho Falls, Idaho Falls
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Menerima pesertaFase 3
- Family First Clinical Research, Idaho Falls
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Menerima pesertaFase 3
- Research Site, Idaho Falls
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Menerima pesertaFase 3
- Rocky Mountain Diab&Osteo Ctr, Idaho Falls
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Menerima peserta
- Rocky Mountain Diabetes, Idaho Falls
Uji klinis Diabetes Tipe 2 di kota lain
- San Antonio, TX37 studi
- Houston, TX31 studi
- Orlando, FL24 studi
- Boston, MA20 studi
- Miami, FL19 studi
- Chicago, IL19 studi
- Dallas, TX19 studi
- Columbus, OH18 studi
- Las Vegas, NV18 studi
- Atlanta, GA17 studi
- San Diego, CA17 studi
- Los Angeles, CA16 studi
Studi lain di Idaho Falls
- Kelebihan Berat Badan7 studi
- Obesitas6 studi
- Tekanan Darah Tinggi3 studi
- Infeksi Pneumokokus3 studi
- Kolitis Ulseratif3 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.